SIG-004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSIG-004
Drug Alias Nameoral anti-inflammatory agent (Signum)SIG-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor modulators
TargetsG-protein coupled receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignum Biosciences INC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignum Biosciences INC
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A